Category: Cancer Treatment
Asia Cancer Treatment
-
Breast Tissue Markers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... biopsies and surgeries, ensuring accurate diagnosis and targeted treatment of breast cancer. According to market analysis, the global breast tissue markers market is expected to grow from US$ 3.3 billion in 2025 to US$ 6.1 ... Read More
-
Breast Recurrence Score Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... rate (CAGR) of 10.00% during the forecast period. Rising global breast cancer incidence, technological progress in genomic profiling, and the increasing preference for non-invasive diagnostic methods are driving the market forward. Market Insights Breast recurrence ... Read More
-
Global & Vietnam Cancer Therapeutics Market to 2031
... access to cancer care services. The Vietnamese Ministry of Health has teamed up with global pharma companies to increase the availability of oncology drugs within public healthcare facilities. These efforts have helped bring innovative cancer ... Read More
-
Global & South Korea Cancer Therapeutics Market to 2031
... approximately 274,488 new cancer cases that year. Thyroid cancer topped the list as the most frequently diagnosed, followed by lung, colorectal, breast, and stomach cancers. This growing cancer burden is fueling a corresponding surge in ... Read More
-
Global & Turkey Cancer Therapeutics Market to 2031
... including immunotherapy and targeted therapies. In response, the Turkish government has launched several initiatives to enhance the development and accessibility of such treatments. One key effort is the Ministry of Health's National Cancer Control Program, ... Read More
-
Global & Bangladesh Cancer Therapeutics Market to 2031
... producing generic cancer medications, which helps make treatments more affordable and accessible to a larger segment of patients. However, the market faces challenges including the absence of widespread cancer screening programs, limited availability of advanced ... Read More
-
Global & Malaysia Cancer Therapeutics Market to 2031
... improve patient survival rates, the Ministry of Health established the National Cancer Control Blueprint. Data from the National Cancer Registry (NCR) indicates that approximately 50,000 new cancer cases are diagnosed annually in Malaysia, with breast, ... Read More
-
Global & Thailand Cancer Therapeutics Market to 2031
... inhibitors like Keytruda (pembrolizumab) and Opdivo (nivolumab) have become more accessible in Thailand, offering promising options for patients with melanoma, non-small cell lung cancer (NSCLC), bladder cancer, and other cancers. These therapies enhance the immune ... Read More
-
Global & Japan Cancer Therapeutics Market to 2031
... least 500,000 individuals in the country are aged 65 or older. Projections from Japan’s National Institute of Population and Social Security Research estimate that by 2050, 37.7% of the population will fall into this age ... Read More
-
Global & Indonesia Cancer Therapeutics Market to 2031
... new cancer cases and nearly 300,000 cancer-related deaths. Factors such as a large population base, tobacco use, poor dietary habits, and environmental pollution are key contributors to the increasing incidence of cancer. In response, the ... Read More
-
Global & Russia Cancer Therapeutics Market to 2031
... saw over 600,000 new cancer cases in 2023, alongside approximately 300,000 cancer-related deaths. The most common cancers include lung, breast, colorectal, and prostate cancers, with lung cancer posing a major challenge due to high smoking ... Read More
-
Global & Singapore Cancer Therapeutics Market to 2031
... one of the top causes of mortality in the country. As global cancer care evolves, Singapore has emerged as a prominent center for oncology drug development, attracting both domestic and international pharmaceutical companies to conduct ... Read More
-
Global & China Cancer Therapeutics Market to 2031
... diagnoses and 3 million cancer-related deaths were reported in the country in 2020. Alarming statistics from WHO suggest that, on average, seven individuals are diagnosed with cancer every minute in China, and four die from ... Read More
-
Global & Philippines Cancer Therapeutics Market to 2031
... and the Philippine Health Insurance Corporation (PhilHealth), have significantly contributed to enhancing access to cancer care services and medications. Despite these advancements, challenges persist—particularly the high cost of therapies and limitations within the country’s healthcare ... Read More
-
Global & Taiwan Cancer Therapeutics Market to 2031
... in managing conditions such as non-small cell lung cancer (NSCLC), melanoma, and head and neck cancers. Additionally, the growing trend toward personalized therapies tailored to patients' genetic profiles has fueled demand for companion diagnostics and ... Read More
-
Global & India Cancer Therapeutics Market to 2031
... cancer, lung cancer, leukemia, and non-Hodgkin lymphoma are among the most frequently observed types. Specifically, breast cancer accounted for 13.5% (178,361) of all cancer cases and 10.6% (90,408) of cancer-related deaths, with a cumulative risk ... Read More
-
Mitotane Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... to grow from a valuation of US$ 17.14 million in 2025 to US$ 24.2 million by the end of 2032, registering a CAGR of 5.05% over the forecast period from 2025 to 2032. Mitotane, a ... Read More
-
Medical Nutrition Market, By Nutrition Type (Proteins, Carbohydrates, Multivitamins & Antioxidants, Amino Acids, Fibers, Minerals, and Others), By Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes, and Others), By Patient Type (Infant Nutrition, Adult Nutrition, and Geriatric Nutrition), By Route of Administration (Oral, Enteral, and Parenteral), By End User (Hospitals, Home Care Settings, Long Term Care, and Ambulatory Surgical Centers), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... as the rising consumer awareness about nutrition, innovative new product launches catering to specific dietary requirements, and promotion of healthy diets by governments and health organizations have also contributed to the rising demand. It is ... Read More
-
Asia-Pacific Biomarkers for Hematopathology Market Research Report Information by Type (Products and Services), by Cancer Type (Lymphoma and Leukemia), by Technology Category (NGS, PCR, IHC, FISH and Others) Industry Forecast to 2032
... markers for a range of hematological conditions, including myeloproliferative illness, leukemia, lymphoma, and anemia. These biomarkers, which are typically proteins, genes, or metabolites, can be found and measured using contemporary diagnostic methods including next-generation sequencing ... Read More
-
Soft Tissue Sarcoma Market Research Report By Diagnosis (Biopsy, Ultrasound Scan, Magnetic Resonance Imaging (MRI), and others), By Treatment (Targeted Therapy, Chemotherapy, Anti-Angiogenesis Drugs, Radiation Therapy, and Surgery) By End Use (Hospitals and Clinics, Cancer Research Centers, and Others), And By Region (North America, Europe, Asia-Pacific, And Rest of the World) Forecast Till 2032
... forecast period (2024-2032). New product introductions, growing usage of newer medicines, and a wider target demographic are all significant market drivers boosting growth. The launch of new goods, widespread use of innovative treatments, and an ... Read More
-
BRICS Cancer Therapeutics Market Report (2021–2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
... Summary and BRICS Cancer Therapeutics Market Analysis: The cancer therapeutics market in BRICS is experiencing significant growth driven by growing burden of breast and lung cancer and surging investments in oncology research . For instance, ... Read More
-
ASEAN Cancer Therapeutics Market Report (2021–2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
... Summary and ASEAN Cancer Therapeutics Market Analysis: The increasing incidence of cancer—fueled by an aging population; urbanization; and lifestyle changes such as smoking, unhealthy diets, and reduced physical activity—boost the market growth in these countries. ... Read More
-
Asia Pacific Cancer Therapeutics Market Report (2021–2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
... Summary and Asia Pacific Cancer Therapeutics Market Analysis: Cancer rates are escalating in these countries due to the rapidly aging population; increasing life expectancy; and lifestyle changes such as poor diet, smoking, and lack of ... Read More
-
Japan Locally Advanced Pancreatic Cancer Market - 2025-2033
... advanced pancreatic cancer (LAPC) in the market refers to a stage of the disease where the tumor remains confined to the pancreas and surrounding regional structures but has not metastasized to distant organs such as ... Read More
-
Asia-Pacific Cancer Biomarker Testing Market Research Report by Type (Product and Services), by Testing Type (Single Gene Testing and Multiple Gene Testing), by Region (China, India, Japan, South Korea, Singapore, Australia, New Zealand, Hong Kong, Thailand, and Taiwan) Industry Forecast to 2032
... markers, such as molecules or genes, in blood, tissues, or other physiological fluids to ascertain the presence, progression, or risk of cancer. Early identification, diagnosis, prognosis, and treatment selection can be facilitated by these biomarkers, ... Read More
Research Assistance
